Vasopressin Plasma Concentrations in Patients Receiving Exogenous Vasopressin Infusion for Septic Shock
NCT03014063 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 18
Last updated 2019-01-31
Summary
This is a prospective observational cohort trial evaluating a single plasma vasopressin concentration in patients receiving exogenous, adjunctive vasopressin for septic shock. The trial is designed to determine whether plasma vasopressin concentration influences the likelihood of hemodynamic response to exogenous vasopressin therapy.
Conditions
- Septic Shock
Sponsors & Collaborators
-
The Cleveland Clinic
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-11-30
- Primary Completion
- 2017-06-30
- Completion
- 2017-06-30
Countries
- United States
Study Locations
More Related Trials
-
Effect of Vasopressin on Kidney and Cardiac Function in Septic Shock
NCT06125184 ·Status: RECRUITING ·Phase: NA
-
Discontinuation Order of Vasopressors in Septic Shock
NCT01493102 ·Status: TERMINATED ·Phase: NA
-
Hemodynamic Effects of Vasopressin in Early Septic Shock Stage
NCT02053675 ·Status: COMPLETED ·Phase: NA
-
Angiotensin II vs. Vasopressin in Septic Shock
NCT05193370 ·Status: WITHDRAWN ·Phase: PHASE4
-
Use of Vassopresin in Septic Shock Prospective Multicenter Observational Study With Medication
NCT07255378 ·Status: RECRUITING
-
Early Versus Late Adjunctive Vasopressin in Septic Shock
NCT06709573 ·Status: RECRUITING ·Phase: PHASE4
-
Dopamine Versus Norepinephrine for the Treatment of Vasopressor Dependent Septic Shock
NCT00604019 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Early Argipressin in the Management of Intensive Care Patients With Norepinephrine-refractory Vasoplegic Shock
NCT07063680 ·Status: RECRUITING ·Phase: PHASE3
-
Norepinephrine Exerts an Inotropic Effect at the Early Phase of Human Septic Shock
NCT02750683 ·Status: COMPLETED
-
Norepinephrine / Vasopressin Combination for Resuscitation in Septic Shock
NCT04302584 ·Status: COMPLETED ·Phase: NA
-
Crystalloid Liberal or Vasopressors Early Resuscitation in Sepsis
NCT03434028 ·Status: COMPLETED ·Phase: PHASE3
-
Protocol-driven Hemodynamic Support for Patients With Septic Shock
NCT00335907 ·Status: UNKNOWN ·Phase: NA
-
Midodrine Use in Septic Shock
NCT03706053 ·Status: TERMINATED ·Phase: PHASE3
-
Dexmedetomidine and Vasopressin in Septic Shock
NCT06302998 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
The Construction and Application of Therapeutic System of Intelligent Decision-Oriented Hemodynamic Organized Therapy for Shock Patients
NCT05886192 ·Status: UNKNOWN ·Phase: PHASE4
-
The Impact of Early Norepinephrine Administration on Outcomes of Patients With Sepsis-induced Hypotension
NCT05774054 ·Status: COMPLETED ·Phase: NA
-
Cerebral Oxygenation in Septic Patients Using Vasopressors - the Conscious Study
NCT02237833 ·Status: TERMINATED
-
Midodrine During Recovery From Septic Shock
NCT02771158 ·Status: WITHDRAWN ·Phase: PHASE4
-
Early Use of Norepinephrine in Septic Shock Resuscitation
NCT01945983 ·Status: COMPLETED ·Phase: NA
-
Mechanistic Assessment of Norepinephrine Therapy vs. Angiotensin-II in Septic Shock
NCT06746753 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Norepinephrine Equivalent Dose of Vasopressin, Phenylephrine and Epinephrine in Septic Shock
NCT06499467 ·Status: RECRUITING
-
The Effect of Terlipressin on Intesitnal Function in Septic Shock Patients
NCT02306239 ·Status: UNKNOWN ·Phase: NA
-
Terlipressin in Septic Shock: Effects on Microcirculation
NCT00995839 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Hemodynamic Response to Angiotensin-II When Used as the Second Vasopressor Agent for Septic Shock
NCT06122987 ·Status: RECRUITING ·Phase: PHASE4
-
Continuous Infusion of Terlipressin in Septic Shock
NCT00481572 ·Status: COMPLETED ·Phase: PHASE2